Clinical trials
Observational Malnutrition trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 6 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Nutrition | 6 |
| Instituto de Investigación Hospital Universitario La Paz | 2 |
| Outcomes'10 | 2 |
| Casen Recordati S.L. | 1 |
| Corporacion Parc Tauli | 1 |
| Fundacin Biomedica Galicia Sur | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Germans Trias i Pujol Hospital | 1 |
| Hospital Clinic of Barcelona | 1 |
| Hospital Viamed Valvanera, Spain | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malnutrition | 24 |
| Sarcopenia | 4 |
| Diabetes Mellitus | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Exocrine Pancreatic Insufficiency | 2 |
| Liver Cirrhosis | 2 |
| Anorexia Nervosa | 1 |
| Body Weight | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.